The present study was conducted to examine the effect of activin A on growth of rat hepatocytes. EGF induced a 10-fold increase in DNA synthesis as assessed by [3HI thymidine mRNA for iBA subunit of activin was detected only slightly in unstimulated hepatocytes, but markedly increased at 48 h after the addition of EGF. To determine whether endogenously produced activin A affects DNA synthesis, we examined the effect of follistatin, an activin-binding protein that blocks the action of activin A. An addition of follistatin significantly enhanced EGF-induced DNA synthesis. Finally, in partial hepatectomized rat, expression of mRNA for #A subunit in liver was markedly increased 24 h after the partial hepatectomy. These results indicate that activin A inhibits initiation ofDNA synthesis in hepatocytes by acting on its own receptor and that activin A acts as an autocrine inhibitor of DNA synthesis in rat hepatocytes. (J.
Introduction
Activin A is a homodimeric protein with molecular mass of 25 kDa (1) . Structure of activin A shares homology with TGF-,3 and activin A is now considered to be a member of TGF-# activin A modifies growth and differentiation of target cells. Thus, activin A increases number ofgonadotrophs in pituitary (2) and modulates differentiation ofovarian granulosa cells (3, 4) . In addition to the actions on pituitary-gonadal axis, activin A induces differentiation oferythroid cells (5) and megakaryocytes (6) , modifies growth and differentiation of neuronal cells (7, 8) , and acts as an inducer of mesoderm during development (9-1 1 ).
We have reported that isolated rat hepatocytes produce glucose in response to activin A ( 12), an observation indicating that parenchymal liver cells are one of target cell systems of activin A. It is shown that TGF-fl is a potent inhibitor of cell growth in parenchymal liver cells in primary culture ( 13).
During liver regeneration, mRNA for TGF-j is expressed in nonparenchymal cells of the liver ( 14) . TGF-# is thus synthesized in nonparenchymal cells and is secreted probably as an inactive form. Although the mechanism of activation of TGF-,B in liver is not totally understood, it is postulated that TGF-,B acts as a paracrine growth inhibitor of hepatocytes. Since activin A modulates cell growth and differentiation in many cell systems, and since hepatocytes possess a receptor system for activin A, it is an interesting possibility that activin A also modifies growth of hepatocytes. In the present study, we examined the effect of activin A on DNA synthesis in cultured rat hepatocytes. We report here that activin A is a potent inhibitor of initiation of DNA synthesis in rat parenchymal liver cells. Furthermore, activin A is synthesized and is released from hepatocytes when the growth is stimulated by either EGF or hepatocyte growth factor (HGF)' /scatter factor. Hence, activin A acts as an autocrine negative regulator of DNA synthesis in parenchymal liver cells and presumably plays a significant role in the regulation of hepatocyte growth.
Methods
Materials. Recombinant human activin A was obtained as described previously ( 15) . Recombinant human follistatin was provided by Prof. M. Muramatsu of Saitama Medical College. Human recombinant HGF/Scatter Factor (16) was provided by Prof. T. Nakamura of Osaka University (Osaka, Japan). Human recombinant TGF-fl, was purchased from King Jozo (Himeji, Japan). Bovine inhibin A was purified from ovarian follicular fluid as described previously (17) . EGF was obtained from Collaborative Research (Lexington, MA).
[3H]Thymidine (6. ( 18) . Cells were plated in a 24-well collagen-coated dish at a density of 5 X 104/well in Williams' E medium containing 5% fetal bovine serum, 10 nM insulin, 1 nM dexamethasone, streptomycin, and penicillin unless otherwise mentioned. After 3 h, cells were washed and were then incubated in fresh serum-free medium containing 0.1 nM insulin, 0.1% BSA and either EGF (1 nM) or HGF/scatter factor (10 ng/ml). Nonparenchymal liver cells were cultured as described by Shimaoka et al. ( 19) . Partial hepatectomy (70%) as described by Higgins and Anderson (20) activin A in the presence or absence of unlabeled agents. At the end of incubation, cells were washed four times with ice-cold binding buffer and lysed with 1% Triton X-100. Measurement ofactivity ofactivin A. Bioactivity of activin A was determined by measuring the ability to induce differentiation of murine erythroleukemia cells (6) . Murine erythroleukemia cells (F5-5 cells) were incubated for 5 d in the presence of known amount of activin A or serially diluted conditioned medium. Differentiation of erythroleukemia cells was assessed by staining hemoglobin with dianisidine (6) . To confirm that the differentiation-inducing activity was caused by activin, we examined whether or not the erythroid differentiation activity was blocked by follistatin, an activin binding protein that blocks the action of activin ( 16) .
Riboprobe construction. Rat inhibin #,A probe was subcloned into pGEM 7Zf(-) plasmid (Promega Biotec, Madison, WI). The resultant construct was linearized with Pst 1. The transcription with T7 RNA polymerase (Takara, Tokyo, Japan) generated a 384-base riboprobe comprised of 43 bases on pGEM7Zf(-) and 341 bases complementary to the rat inhibin #BA mRNA. Riboprobe synthesized with T7 RNA polymerase was labeled using [32PJUTP (New England Nuclear) for RNase protection assay and using [35S]UTP (New England Nuclear) for in situ hybridization. At the end oftranscription, 5 ;g DNase I (Takara) was added, the mixture was incubated at 37°C, and labeled riboprobe was recovered by ethanol precipitation.
[35S]UTP-labeled riboprobe was further hydrolyzed in 80 mM NaHCO3, 120 mM Na2CO3, 10 mM dithiothreitol for 20 min at 60°C, and was then recovered by ethanol precipitation.
Detection ofmRNA for Inhibin O, subunit by ribonuclease protection assay. Total RNA was extracted from cultured hepatocytes or liver after partial hepatectomy by the method of Chomzynski and Sacchi (25) . RNase protection assay was performed using RPA II kit (Ambion Inc., Austin, TX) according to the manufacturer's instructions.
Briefly, 10 ,ug of total RNA was hybridized with 5 X 0I cpm of each 32P-labeled riboprobe for 16 h at 450C, followed by digestion with RNase A and RNase TI at 370C. The resultant protected hybrids were isolated by ethanol precipitation and separated on a 5% polyacrylamide/8-M urea denaturing gel. Dried gel was exposed to Kodak XAR-2 film at -80'C for autoradiogram.
In situ hybridization. In situ hybridization was performed in cultured hepatocytes. Briefly, cultured hepatocytes were fixed with 4% paraformaldehyde in PBS for 5 min. After rinsing with PBS, cells were dehydrated in ethanol. Hybridization was performed for 16 h at 500C using 3"S-labeled antisense RNA probes. Cells were washed 2x SSC containing 50% formamide at 500C for 30 min, and were treated with RNase A (25 ,g/ml) for 30 min at 370C. After washing twice with 2X SSC for 20 min at 50C and then twice with 0.2X SSC for 20 min at 50'C, the slides were dehydrated in ethanol and coated with Kodak NTB-2 emulsion. The exposure time was 2 wk at 4VC. To rule out false positive in situ hybridization, 3S-labeled sense RNA probe for rat inhibin ftA was examined in the same series of slides under identical conditions.
Analysis ofmRNA by reverse Transcription PCR. Double-stranded cDNA was synthesized from poly-A RNA obtained by using oligo deoxythymidylate latex (Takara) (26) . To avoid contamination ofgenomic DNA, samples with or without treatment of Moloney murine leukemia virus were prepared. One tenth of the resulting cDNA was used as a template for PCR. Oligonucleotide primers were designed on the basis of DNA sequence of rat inhibin subunits (27) . The sense and antisense primers for inhibin a were 5'-TGACT`TCAGCCCAGCTGT-GG-3' and 5'-TTCACCGGCCCAGGGTTCAG-3', respectively. The sense and antisense primers for inhibin ,BAwere 5'-GAACAGTGCCAG-GAGAGCGG-3'and5'-AGGTTGGCAAAGGGGCTGTG-3',respectively. For inhibin l., the sense and antisense primers were 5'-GTG-GTGCCTGTGTTCGTGGA-3' and 5'-TTCACCGGCCCAGGG-TTCAG-3', respectively. Random hexamer (Pharmacia Fine Chemicals, Piscataway, NJ) was used to generate cDNA fragment. The temperature program for the amplification was 30 cycles of I min at 94°C, I min at 60°C, and 1 min at 72°C. The products were separated on a 2% agarose gel and visualized with eithidium bromide.
Results
Effect ofactivin A on DNA synthesis in cultured rat heptocytes.
In the presence of insulin, EGF induced 10-fold increase in DNA synthesis as assessed by [3H]thymidine incorporation in cultured hepatocytes. As demonstrated in Table I , 1 nM activin A almost completely blocked DNA synthesis induced by EGF. The inhibitory effect was comparable to that of 100 pM TGF- (27) (28) (29) . We then examined whether activin A was produced in hepatocytes. Bioactivity of activin A was determined by measuring the ability to induce differentiation of erythroleukemia cells (6) . Bioactivity ofactivin A was detected in conditioned medium of hepatocytes incubated with EGF. Fig. 4 Hepatocytes were cultured with I nM EGF and 0.1 nM insulin for indicated time. Total mRNA was extracted and mRNA for IfA subunit was measured by ribonuclease protection assay as described in Methods.
of activin A (16) . As demonstrated in Fig. 7 , basal [3H]-thymidine uptake increased slightly as a function of cell density. EGF increased [3H] thymidine incorporation at any cell density, but the stimulatory action of EGF was attenuated at a high cell density. Follistatin significantly enhanced EGF-mediated DNA synthesis, and the stimulatory action of follistatin was observed even in hepatocytes cultured in a high cell density. Expression ofmRNAfor 1Asubunit in regenerating liver. To examine whether activin A was expressed in hepatocytes in vivo, we measured mRNA expression of 13A subunit in liver after partial hepatectomy. As depicted in Fig. 8 , mRNA for flA subunit was expressed slightly in intact liver and disappeared at 12 h. The mRNA expression was then markedly increased 24 h after the hepatectomy and was declined thereafter. These results suggest that activin A is produced in liver after partial hepatectomy. The present results provide for the first time evidence that activin A is produced in parenchymal liver cells. Of particular interest is the fact that activin A is released when growth of hepatocytes is induced by an addition of EGF or HGF/scatter factor. In addition, production ofactivin A becomes detectable later than 24 h of the addition of EGF. As shown in Fig. 2 , activin A inhibits initiation of DNA synthesis by acting on a point located after 36 h ofthe addition ofEGF. Taken together, activin A is produced at time when it exerts the inhibitory effect on DNA synthesis. Therefore, it is likely that activin A acts as a negative regulator of cell growth in hepatocytes. As shown in Fig. 7 , follistatin, which blocks the action of activin A ( 16), augments EGF-induced DNA synthesis. This result supports the notion that endogenously produced activin A attenuates EGF-mediated DNA synthesis in cultured hepatocytes. It is quite likely that endogenous activin A acts as an autocrine inhibitor ofinitiation ofDNA synthesis in hepatocytes, production of which is turned on by the stimulator of cell growth.
The role of activin A as an autocrine inhibitor of DNA synthesis in hepatocytes is intriguing in view of the history of the research for liver chalones. In the 1950s, hypotheses as to tissue homeostasis were proposed based on the presence ofstimulators or inhibitors of cell growth. Ifthe inhibitor is produced by the differentiated hepatocytes, partial hepatectomy would decrease the concentration ofthe inhibitor and cells start proliferation. Subsequently, the cell number is increased and the concentration of the inhibitor becomes high enough to block cell growth. According to this "chalone" hypothesis (32), rate of cell proliferation is under the control ofa tissue-specific factor named chalone, which inhibits cell proliferation. Attempts were made to identify the putative liver chalone (33) (34) (35) (37) . Subsequently, TGF-f3, a potent inhibitor of hepatocyte growth, is synthesized in nonparenchymal cells (14) . TGF-,3 is produced as an inactive form, and it is postulated that TGF-f3 is taken up into parenchymal cells via the IGF II/mannose 6-phosphate receptor (38) , where TGF-# is activated by a mechanism involving proteolysis. Our 
